Jason Greenhalgh, MD
Urology · Twin Falls, IDNPI 1952478703
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Medtronic at 57.0% of the total. 2025 is the largest year on record at $2,483, more than ten times the $188 reported in 2019.
Across 60 payments — averaging $61.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$293
- Olympus America Inc.$249
- Teleflex LLC$238
- AbbVie$157
- Procept Biorobotics Corporation$145
- plus $491 from 11 others
What the payments were for
- Consulting fees$1003%
- Travel & lodging$1,51941%
- Food & beverage$1,76048%
- Education$2838%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 17 | $2,089 |
| Boston Scientific | 10 | $293 |
| Olympus America Inc. | 4 | $249 |
| Teleflex LLC | 5 | $238 |
| AbbVie(2 entities) | 8 | $157 |
| Procept Biorobotics Corporation | 1 | $145 |
| Comsort, Inc | 1 | $100 |
| Astellas Pharma US Inc | 2 | $98 |
| Valencia Technologies Corporation | 1 | $82 |
| Calyxo, Inc. | 1 | $58 |
| 180 Medical, Inc. | 2 | $37 |
| Urovant Sciences Inc | 2 | $34 |
| Endo Pharmaceuticals Inc. | 2 | $29 |
| Telix Pharmaceuticals | 1 | $23 |
| Bayer | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
| Travere Therapeutics, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,662 in reported general payments places this provider in the 60th percentile of 55 urology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 151 | $105,417 |
| Solifenacin Succinate | 109 | $27,322 |
| Potassium Citrate ErPotassium Citrate | 78 | $11,303 |
| Tamsulosin Hcl | 593 | $9,720 |
| Tolterodine Tartrate ErTolterodine Tartrate | 43 | $6,480 |
| Methenamine Hippurate | 77 | $5,060 |
| Finasteride | 227 | $2,721 |
| Silodosin | 15 | $1,833 |
| Testosterone Cypionate | 23 | $1,404 |
| NitrofurantoinNitrofurantoin Macrocrystal | 17 | $1,369 |
| Cefdinir | 48 | $1,223 |
| Cephalexin | 84 | $1,102 |
| Doxycycline Monohydrate | 33 | $1,059 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 25 | $663 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 120 | $582 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $98 | $105,417151 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 55 urology providers in Idaho.
Other urology in Twin Falls
- Zachary GlaserTwin Falls$15K
- Michael SweeneyTwin Falls$5K
- Joel HancockTwin Falls$4K
- Andrew MazzoneTwin Falls$3K
- Edward MartinezTwin Falls$1K
- Jeremy WeissTwin Falls$1K
- Steven KurtzTwin Falls$623
- Nikolai SopkoTwin Falls$488
- Cory BatesTwin Falls$431
- Sean StroupBoise$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.